GenBody Inc. of Cheonan-si, Chungnam at MEDICA 2019 in Düsseldorf -- COMPAMED Trade Fair
Manufacturers

GenBody Inc.

3-18, Eopseong 2-gil, Seobuk-gu, 31077 Cheonan-si, Chungnam
Korea, Republic
Telephone +82415238993
Fax +82415238991
contact@genbody.co.kr

This company is main exhibitor of

Hall map

MEDICA 2019 hall map (Hall 1): stand B23

Fairground map

MEDICA 2019 fairground map: Hall 1

Our range of products

Product categories

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

Our products

Product category: Immuno assay testing

Influenza A/B Ag

GenBody Influenza A/B Antigen is a chromatographic immunoassay kit for rapid, qualitative, and differential determination of influenza virus type A and type B (not type C) infection from Nasopharyngeal specimens. Antigens of influenza virus type A and type B in the specimens are allowed to react with the anti-influenza A and anti-influenza B monoclonal antibody-coupled gold conjugate followed by reaction with anti-influenza A or anti-influenza B monoclonal antibodies immobilized in the test lines. When the sample contains influenza virus A&B, a visible line appears in the test region on the membrane. GenBody Influenza A/B Antigen is also very useful to directly and differentially detect influenza virus (A/B) from nasal swab.

Specifications
- Store at 2~30℃
- Specimen :Nasopharyngeal swab
- Testing time : 5~10min
- Shelf life : 24 months after its manufacture date

More Less

About us

Company details

Founded in 2012 with the pursuit for human and global health, GenBody Inc. creates innovative technologies for the development of raw materials for diagnostic use. We offer diagnostic total solution such as rapid diagnostic tests (RDTs), fluorescent immuno-diagnostic tests, ELISA, molecular diagnostic tests (MDx) and clinical chemistry.With over 20 years combined experience in the diagnostic industry and through vast bio-networks between several key institutes, universities, and hospitals, our core strength is in R&D. we specialize in developing monoclonal antibodies and recombinant antigens in-house at our facility in South Korea.

We also have patented technologies including fluorescent immuno-diagnostics, which will be one of the major IVD technologies of the future.

Our Mission statement is to bring Technology to Your life.
We continuously develop innovative diagnostics and pharmaceutical technologies for improving your quality of life.

More Less